Get the Stockscreener App
5.10
2.30%
-0.11
Optimizerx Corp stock is traded at $5.10, with a volume of 31,086.
It is down -2.30% in the last 24 hours and down -32.49% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$5.21
Open:
$5.2
24h Volume:
31,086
Relative Volume:
0.26
Market Cap:
$95.46M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-6.2195
EPS:
-0.82
Net Cash Flow:
$153.00K
1W Performance:
-7.79%
1M Performance:
-32.49%
6M Performance:
-52.07%
1Y Performance:
-40.05%
1-Day Range:
$5.05
$5.27
1-Week Range:
$5.0435
$5.59
52-Week Range:
$5.0435
$16.64
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Rice Hall James & Associates LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizRx stock hits 52-week low at $5.42 amid market challenges - Investing.com India
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - The Manila Times
Optimizerx stock hits 52-week low at $6.29 amid market shifts - Investing.com
Squarepoint Ops LLC Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Renaissance Technologies LLC - Defense World
American Century Companies Inc. Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? - Yahoo Finance
Optimizerx stock hits 52-week low at $6.92 amid market shifts By Investing.com - Investing.com South Africa
Optimizerx stock hits 52-week low at $6.92 amid market shifts - Investing.com Australia
OptimizeRx's SWOT analysis: digital health firm faces growth challenges By Investing.com - Investing.com UK
OptimizeRx's SWOT analysis: digital health firm faces growth challenges - Investing.com
Rhumbline Advisers Increases Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of New York Mellon Corp - Defense World
Divisadero Street Capital Management LP Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
OptimizeRx expands pharma client engagement to $10M - Investing.com
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a - The Bakersfield Californian
OptimizeRx Launches Novel Brand Eligibility Technology - Martechcube
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - ForexTV.com
Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00 - Defense World
Vanguard Group Inc. Raises Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00 - Defense World
A Closer Look at 5 Analyst Recommendations For OptimizeRx - Benzinga
Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 - Yahoo Finance
OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK
Contrasting OptimizeRx (NASDAQ:OPRX) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) - Defense World
Earnings call: OptimizeRx reports solid growth, misses revenue target - Investing.com
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates - MSN
OptimizeRx Reports Second Quarter 2024 Financial Results - StockTitan
Institutional investors may adopt severe steps after OptimizeRx Corporation's (NASDAQ:OPRX) latest 24% drop adds to a year losses - Yahoo Finance
Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates - Zacks Investment Research
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Thursday - Defense World
Acadian Asset Management LLC Cuts Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Analysts Issue Forecasts for OptimizeRx Co.'s Q3 2024 Earnings (NASDAQ:OPRX) - MarketBeat
Q3 2024 Earnings Estimate for OptimizeRx Co. (NASDAQ:OPRX) Issued By B. Riley - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Forecasted to Earn Q2 2024 Earnings of ($0.26) Per Share - Defense World
OptimizeRx Co. (NASDAQ:OPRX) to Post Q2 2024 Earnings of ($0.26) Per Share, B. Riley Forecasts - MarketBeat
OptimizeRx (NASDAQ:OPRX) Coverage Initiated by Analysts at B. Riley - MarketBeat
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - ForexTV.com
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by BNP Paribas Financial Markets - Defense World
OptimizeRx adapts to US privacy laws for pharma marketing - Investing.com
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing ... - NRToday.com
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - StockTitan
RPC (NYSE:RES) Shares Down 4% - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $16.00 Average Target Price from Analysts - MarketBeat
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | CFO/COO |
Oct 03 '24 |
Option Exercise |
0.00 |
16,622 |
0 |
31,387 |
| Odence-Ford Marion | General Counsel and CCO |
Oct 03 '24 |
Option Exercise |
0.00 |
6,649 |
0 |
25,147 |
| Silvestro Stephen L | Chief Commercial Officer |
Oct 03 '24 |
Option Exercise |
0.00 |
6,649 |
0 |
79,495 |
| Besch Doug | Chief Product Officer |
Oct 03 '24 |
Option Exercise |
0.00 |
3,324 |
0 |
11,172 |
| FEBBO WILLIAM J | CEO |
Apr 18 '24 |
Option Exercise |
0.00 |
28,895 |
0 |
582,035 |
| Spangler Patrick D | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
32,181 |
| Vos Ellen O'Connor | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
49,488 |
| WASSON GREGORY D | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
34,029 |
| HALAS GUS D | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
80,926 |
| Lang James Paul | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
54,758 |
0.73%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):